Searchable abstracts of presentations at key conferences in endocrinology

ea0037s15.1 | Puberty: new mechanisms | ECE2015

Epigenetics of Female Puberty

Ojeda Sergio , Lomniczi Alejandro , Wright Hollis , Toro Carlos

A prevailing concept regarding the mechanism controlling the timing of puberty proposes that GnRH release from the hypothalamus increases at puberty due to a loss of transsynaptic inhibition, accompanied by an increase in neuronal/glial excitatory inputs to GnRH neurons. Without negating the importance of this intercellular communication process, recent evidence suggests that a critical inhibitory/excitatory Yin-Yang mechanism regulating the advent of puberty is epigenetic in ...

ea0037gp.25.05 | Thyroid – nodule | ECE2015

Sox9 is expressed in thyroid follicular cells and regulates the expression of thyroid differentiation genes

Lopez-Marquez Aristides , Carrasco-Lopez Carlos , Santisteban Pilar

The transcription factor Sox9 is a member of the HMG-box-DNA binding family essential for chondrocyte differentiation, sexual determination, and the maintenance of the stem/progenitor cells in several tissues. Furthermore, Sox9 is involved in the development of endoderm-derived-organs. Owing to the endodermic origin of the thyroid, we proposed to study the expression of Sox9 in thyroid follicular cells and its regulation by TSH and TGFβ, two main factors involved in thyro...

ea0037ep531 | Diabetes (complications & therapy) | ECE2015

Is dyslipidaemia adequately controlled in type 2 diabetics in primary care? Analysis of 183 patients

Cortes-Salazar Carmen Maria , Fernandez-Garcia Jose Carlos

Objectives: To evaluate the degree of control of atherogenic dyslipidaemia in patients with type 2 diabetes mellitus (T2DM).Methods: Retrospective cohort study which included patients with T2DM followed in a primary care setting. Patients were classified according to the following criteria: strict control of dyslipidaemia (LDL <100 mg/dl and triglycerides <150 mg/dl), partial control of dyslipidaemia (LDL ≥100 mg/dl or triglycerides ≥...

ea0032p292 | Clinical case reports - Thyroid / Others | ECE2013

Parathyroid carcinoma: an atypical case in a patient submitted to Bariatric surgery

Sobrino Paula Sanchez , Catalina Pablo A. Fernandez , Alvarez Carlos Alvarez

Background: Parathyroid carcinoma accounts for <1% of cases of primary hyperparathyroidism. Clinical presentation is usually related to severe hypercalcemia associated to elevated serum PTH (three times above the upper limit). These values are so much higher than in primary hyperparathyroidism due to a benign adenoma. Moreover, 30–75% of patients had a palpable neck mass.Clinical case: Fifty one-year-old male, submitted to bariatric surgery by a...

ea0023oc1.3 | Oral Communications 1 | BSPED2009

IGF1R gene expression in patients with idiopathic short stature according to GH and IGF1 status

Milani Soraya Sader , Custodio Rodrigo , Martinelli Carlos Eduardo

The aim of this study was to analyze IGF1R gene expression in patients with idiopathic short stature (ISS) and correlate it with their GH and IGF1 status. In a previous study, we reported lower final height in subjects with ISS and GH peak ≥40 mU/l (Group1, n=16) compared to those with ISS and GH peak between 20 and 40 mU/l (Group2, n=15), after stimulation test (ITT) performed before or during puberty. Patients were 16–24 (Group1) and 15–26 (Grou...

ea0020p257 | Bone/Calcium | ECE2009

Primary hyperparathyroidism surgery: team report 2002–2008

Allen Miguel , Rafael Ana , Xio Carlos , Fernandes Luis , Torrinha Joaquim

Introduction: Single adenoma is the most frequent cause of Primary hyperparathyroidism (HPT1). Surgical excision has a high success rate, particularly when associated with a fast intraoperative intact parathyroid hormone assay (PTHi).Aim: Evaluate the success rate of primary hyperparathyroidism surgery in our unit.Methods: Descriptive study of the last 33 consecutive HPT1 patients who undertook surgery, 27 of which with PTHi. The P...

ea0056p664 | Growth hormone IGF axis - basic | ECE2018

IGF-I is not suppressed in adolescents submitted to resistance training and can be a marker of training status

Correa Jr Marcos , Filho Hugo Tourinho , Martinelli Jr Carlos

Background: Regular physical exercise during childhood and adolescence can promote growth and development of muscle and bone mass. Although physical exercise is closely linked to the anabolic function of the GH /IGF-I axis the real impact of resistance training on GH/IGF axis is still unclear. The kinetics of IGF-I and IGFBP-3 during chronic training is not fully understood yet and an initial catabolic phase followed by an later anabolic phase has been reported in swimmers.</p...

ea0056p665 | Growth hormone IGF axis - basic | ECE2018

Effects of zinc, magnesium and vitamin B6 (ZMA) supplementation on serum IGF-I, IGFBP-3 and Testosterone concentrations in young athletes

Cerqueira Henrique , Filho Hugo Tourinho , Martinelli Jr Carlos

Background: The GH-IGF system plays an important role in strength gain. Some studies suggest that Zinc, Magnesium and Pyridoxine (ZMA) supplementation could increase GH/IGF and testosterone levels in young subjects. This hypothetical increase could lead to significant changes in body composition. ZMA is a very popular supplement, easily found in specialty stores, and it is presumed to increase GH, IGF-I and testosterone levels. However, studies are divergent regarding its effi...

ea0056p967 | Male Reproduction | ECE2018

Erectile Dysfunction – The hidden sickness we don’t seek

Roque Catarina , Capitao Ricardo , Ferrinho Catia , Duarte Sequeira , Vasconcelos Carlos

Introduction: Erectile dysfunction (ED) is highly prevalent and negatively impacts the patient’s and the partner’s quality of life. It is a well-established red flag for ongoing neuro-vascular disease and a predictor of coronary, cerebral and peripheral arterial disease (PAD). Our aim was to document how often do clinicians investigate ED and use it as a predictor of neuro-vascular pathology to trigger a thorough revision of cardiovascular risk factors (CVRF). This a...

ea0092op-03-03 | Oral Session 3: Signalling in Thyroid cancer | ETA2023

Involvement of mapk-scaffold proteins iqgap in thyroid cancer

Carrasco Lopez Carlos , Makiadi-Alvarado Jennifer , Santisteban Pilar , Zaballos Miguel

Undifferentiated thyroid carcinomas are extremely aggressive and currently lack effective treatment. Aberrant RAS-ERK signaling, triggered mainly by BRAF and RAS mutations, is responsible for the occurrence and progression of most thyroid carcinomas, which led to the clinical use of small kinase inhibitors targeting kinases of the pathway. The results were disappointing, because of the emergence of resistance and high-associated toxicity. A more specific approach, targeting si...